Bio View (Israel) Market Value

BIOV Stock  ILS 26.20  0.90  3.56%   
Bio View's market value is the price at which a share of Bio View trades on a public exchange. It measures the collective expectations of Bio View investors about its performance. Bio View is trading at 26.20 as of the 27th of November 2024, a 3.56 percent increase since the beginning of the trading day. The stock's open price was 25.3.
With this module, you can estimate the performance of a buy and hold strategy of Bio View and determine expected loss or profit from investing in Bio View over a given investment horizon. Check out Bio View Correlation, Bio View Volatility and Bio View Alpha and Beta module to complement your research on Bio View.
Symbol

Please note, there is a significant difference between Bio View's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio View is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio View's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bio View 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bio View's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bio View.
0.00
10/28/2024
No Change 0.00  0.0 
In 31 days
11/27/2024
0.00
If you would invest  0.00  in Bio View on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Bio View or generate 0.0% return on investment in Bio View over 30 days. Bio View is related to or competes with Migdal Insurance, Storage Drop, One Software, Bio Meat, and Israel China. BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cyto... More

Bio View Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bio View's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bio View upside and downside potential and time the market with a certain degree of confidence.

Bio View Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio View's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bio View's standard deviation. In reality, there are many statistical measures that can use Bio View historical prices to predict the future Bio View's volatility.
Hype
Prediction
LowEstimatedHigh
21.9026.2030.50
Details
Intrinsic
Valuation
LowRealHigh
18.3822.6826.98
Details
Naive
Forecast
LowNextHigh
21.6125.9030.20
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
23.4727.9132.36
Details

Bio View Backtested Returns

Bio View secures Sharpe Ratio (or Efficiency) of -0.007, which signifies that the company had a -0.007% return per unit of risk over the last 3 months. Bio View exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bio View's Downside Deviation of 4.08, risk adjusted performance of 0.0238, and Mean Deviation of 2.93 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.56, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Bio View are expected to decrease at a much lower rate. During the bear market, Bio View is likely to outperform the market. At this point, Bio View has a negative expected return of -0.03%. Please make sure to confirm Bio View's total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to decide if Bio View performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.37  

Below average predictability

Bio View has below average predictability. Overlapping area represents the amount of predictability between Bio View time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bio View price movement. The serial correlation of 0.37 indicates that just about 37.0% of current Bio View price fluctuation can be explain by its past prices.
Correlation Coefficient0.37
Spearman Rank Test-0.15
Residual Average0.0
Price Variance1.59

Bio View lagged returns against current returns

Autocorrelation, which is Bio View stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bio View's stock expected returns. We can calculate the autocorrelation of Bio View returns to help us make a trade decision. For example, suppose you find that Bio View has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Bio View regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bio View stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bio View stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bio View stock over time.
   Current vs Lagged Prices   
       Timeline  

Bio View Lagged Returns

When evaluating Bio View's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bio View stock have on its future price. Bio View autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bio View autocorrelation shows the relationship between Bio View stock current value and its past values and can show if there is a momentum factor associated with investing in Bio View.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Bio Stock

Bio View financial ratios help investors to determine whether Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio View security.